GSK reviews Montrose API plant
UK drug major GlaxoSmithKline is examining operations at its active pharmaceutical ingredient (API) manufacturing plant in Montrose, Scotland, with an eye to potential job cuts.
UK drug major GlaxoSmithKline is examining operations at its active pharmaceutical ingredient (API) manufacturing plant in Montrose, Scotland, with an eye to potential job cuts.
Visiongain's third annual conference on Pharmaceutical Anti-counterfeiting Strategies kicks off next week, covering many aspects of the problem from technological deterrents, regulatory developments in the EU and US and the implications for parallel...
Outsourcing-Pharma.com presents its latest round-up of news in the contract development and manufacturing sector, with updates from Rentschler Biotechnologie, Eden Biodesign, Emcure Pharmaceuticals and new start-up Appian Labs.
STMicroelectronics (ST) and Debiotech, which are based in Lausanne and Geneva respectively, have completed the production of an evaluation prototype of their insulin Nanopump.
West has launched the first silicone-oil-free, prefillable syringe, which minimises the quantity of leachables in the pharmaceutical product.